Skip to main content

  • Clinical Experience of the PK Papyrus Covered Stent in Patients With Coronary Artery Perforations: Results From a Multi-Center Humanitarian Device Exemption Survey

    • Posted: 10/01/2022
    • Author:

      David E. Kandzari, Rebecca C. Sarao and Ron Waksman

    • 2022CRM

    Abstract

    Background/purpose

    The PK Papyrus covered coronary stent system (Biotronik AG, Bülach, Switzerland) is intended for treatment of coronary artery perforation (CAP) and is approved for use under a Humanitarian Device Exemption (HDE) in the United States (US).

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details